Skip to content

NAVIMED CAPITAL ADVISORS, LLC

NAVIMED CAPITAL ADVISORS, LLC is a Series C+ and buyout fund in the US writing $5M–$30M checks into healthcare-tech, healthcare-services and pharmaceutical-services.

Stages
Series C+, buyout
Sectors
healthcare-tech, healthcare-services, pharmaceutical-services
Check size
$5M–$30M
Invests in
US-wide
Actively investing
Yes
Founded
2011
Assets under management
$918M

Thesis

NaviMed Capital Advisors, LLC is a private investment firm founded in 2011 and based in Arlington, Virginia, exclusively focused on the healthcare industry. Their investment strategy, termed "Thesis-Driven, Executive-Led," targets control investments in fast-growing, lower middle-market healthcare companies, specifically in healthcare business process outsourcing and specialty healthcare services. They look for profitable private companies with up to $10 million in EBITDA and double-digit annual revenue growth, aiming to foster organic and inorganic growth through market expansion, acquisitions, roll-ups, and consolidations. The firm primarily operates within the United States and typically invests between $5 million and $30 million in equity per transaction, with the capacity for larger investments. As of November 2024, NaviMed Capital manages over $850 million in capital commitments, with its third fund, NaviMed Partners III, closing at $450 million. Regulatory assets under management were approximately $918,788,000 as of December 31, 2024. The firm has managed four closed funds.

Common questions

Does NAVIMED CAPITAL ADVISORS, LLC invest at the Series C+ stage?

Yes. NAVIMED CAPITAL ADVISORS, LLC lists Series C+ and buyout among the stages it invests in.

What check size does NAVIMED CAPITAL ADVISORS, LLC write?

NAVIMED CAPITAL ADVISORS, LLC writes $5M–$30M checks.

Where does NAVIMED CAPITAL ADVISORS, LLC invest?

NAVIMED CAPITAL ADVISORS, LLC invests in the US.